DHA / DOH / MOH exam (UAE) infectious diseases questions

WHO warning signs for severe dengue include persistent vomiting, abdominal pain, mucosal bleeding, lethargy, and a rising hematocrit with falling platelet count, which together reflect plasma leakage and impending shock. A rising hematocrit indicates hemoconcentration from capillary permeability, the hallmark of plasma leakage in dengue hemorrhagic fever/severe dengue. Isolated thrombocytopenia or classic dengue symptoms (retro-orbital pain, myalgia) are expected in uncomplicated dengue and do not by themselves predict severe progression. The critical phase typically begins around defervescence, but defervescence alone is not a warning sign; it is the combination with plasma leakage markers that matters.

• A. These are typical features of classic dengue fever, not markers of progression to severe disease.
• B. Thrombocytopenia alone is common in dengue and does not specifically indicate plasma leakage or severe progression.
• C. Defervescence marks the start of the critical phase but is not itself a warning sign for severe dengue.

The Widal test detects agglutinating antibodies against Salmonella Typhi O and H antigens, but these antigens cross-react with other Salmonella serotypes and with antibodies from prior exposure or vaccination, leading to poor specificity and frequent false positives in endemic areas. Blood culture remains the gold standard for diagnosing typhoid fever because it directly isolates the organism, although sensitivity decreases after antibiotic exposure. Bone marrow culture has higher sensitivity than blood culture, especially after antibiotics, but is not first-line due to invasiveness. A single Widal titer, even if elevated, cannot distinguish current infection from past exposure, so it is considered a supportive rather than confirmatory test.

• B. Antibiotic use lowers blood culture yield, not Widal titers, which are unaffected by antibiotics once antibodies have formed.
• C. The Widal test can technically be performed from the first week, though antibody titers may not yet be diagnostic that early.
• D. While paired sera improve interpretation, the main limitation is cross-reactivity and background seropositivity, not merely timing of sampling.

This patient has uncomplicated Plasmodium falciparum malaria, confirmed by a parasitemia under 5% and absence of any features of severe malaria such as altered consciousness, renal impairment, or acidosis. Current WHO and major guideline recommendations designate oral artemisinin-based combination therapy, such as artemether-lumefantrine, as first-line treatment for uncomplicated falciparum malaria. Intravenous artesunate is reserved for severe or complicated malaria, or when oral therapy cannot be tolerated. Chloroquine is no longer effective in most regions due to widespread P. falciparum resistance, and quinine-clindamycin is an alternative, not first-line, option typically reserved for areas without ACT availability or in pregnancy.

• A. Chloroquine resistance is widespread in P. falciparum and it is no longer recommended for this species.
• B. This regimen is an alternative option, not the first-line choice, when ACT is unavailable or contraindicated.
• C. Intravenous artesunate is reserved for severe malaria, which this patient does not have.

This patient has a classic presentation of brucellosis: prolonged undulant fever, sacroiliitis, hepatosplenomegaly, and exposure to unpasteurized dairy or camel milk, a known risk factor in the Gulf region. Diagnosis is confirmed by blood culture, though Brucella species are slow-growing and require extended incubation (up to 3-4 weeks) or automated continuous-monitoring systems, supplemented by serologic tests such as the serum agglutination test when culture is negative or delayed. Stool culture, malaria testing, and heterophile antibody testing are directed at other causes of fever but do not fit this exposure history and clinical picture of sacroiliitis with hepatosplenomegaly.

• B. Malaria testing is not indicated without travel to an endemic area or a compatible exposure history.
• C. There is no diarrheal illness in this history, making enteric bacterial stool culture inappropriate.
• D. Heterophile antibody testing is used for infectious mononucleosis, which does not match this exposure and joint involvement.

This patient meets criteria for classic fever of unknown origin (FUO): temperature above 38.3°C on several occasions, duration of at least 3 weeks, and no diagnosis despite a reasonable initial outpatient evaluation. The next appropriate step is imaging with CT of the chest, abdomen and pelvis or PET-CT, which can identify occult infections, malignancies (notably lymphoma), or inflammatory foci not apparent on initial basic workup. Empirical antibiotics or steroids should be avoided at this stage because they can mask the underlying disease process and delay definitive diagnosis. Invasive procedures such as laparotomy are reserved for cases where imaging or other targeted tests point to a specific abnormality requiring tissue diagnosis.

• B. Diagnostic laparotomy is overly invasive and is only considered after noninvasive imaging suggests a specific target.
• C. Empirical antibiotics without an identified source risk masking the diagnosis and are not recommended at this stage.
• D. Empirical steroids can suppress fever and inflammatory markers, obscuring the underlying cause, and should be avoided before a diagnosis is reached.

The structured approach to fever in a returning traveler requires correlating the incubation period with the region visited and specific exposures (freshwater contact, insect bites, food and water sources, animal contact) to prioritize a differential diagnosis. Malaria must always be excluded first with a blood smear or rapid diagnostic test in any febrile returning traveler from an endemic area, because it is rapidly progressive and potentially fatal if missed. Freshwater exposure raises suspicion for leptospirosis or schistosomiasis, which should be specifically asked about, but malaria exclusion takes priority given the urgency and lethality of untreated disease. Non-specific tests like Monospot or TB skin testing, or empirical treatment without exclusion of malaria, are inappropriate as first steps in this setting.

• A. A Monospot test is not a first-line screening tool for undifferentiated fever in a traveler and does not consider exposure-specific risks.
• B. Empirical treatment for dengue without excluding malaria or confirming the diagnosis risks missing a life-threatening infection.
• D. Tuberculin skin testing is not useful for acute febrile illness and has a prolonged read time, making it inappropriate as an initial step.

This patient has a CURB-65 score of 5: confusion, urea greater than 7 mmol/L, respiratory rate at least 30/min, blood pressure below 90/60 mmHg (hypotension), and age 65 years or older. A CURB-65 score of 3 or more indicates severe community-acquired pneumonia with a high risk of mortality, requiring hospital admission and assessment for intensive care or high-dependency unit management. Outpatient treatment with oral antibiotics, as suggested by the discharge options, is appropriate only for scores of 0-1 and is clearly unsafe here given his hemodynamic instability and altered mentation. Simple ward observation without escalation planning would also underestimate his severity and mortality risk.

• A. Discharge with oral antibiotics is unsafe in a patient with hypotension, confusion, and tachypnea indicating severe pneumonia.
• B. This underestimates severity; a score this high mandates consideration of intensive or high-dependency care, not routine ward observation alone.
• D. Discharge is inappropriate; a CURB-65 score of 5 indicates severe pneumonia requiring hospital admission, not outpatient management.

This patient has low-severity community-acquired pneumonia with a CURB-65 score of 0 and no comorbidities, making him suitable for outpatient management. Current guidelines recommend oral amoxicillin as first-line empirical therapy for low-severity CAP in otherwise healthy outpatients, targeting Streptococcus pneumoniae, the most common causative organism. Intravenous combination therapy with a cephalosporin and macrolide is reserved for moderate to severe CAP requiring hospitalization. Fluoroquinolones are not first-line for uncomplicated outpatient CAP due to concerns about resistance, adverse effects, and the need to reserve them for specific indications, and broad-spectrum intravenous agents like piperacillin-tazobactam are unnecessary and not indicated for a low-severity case treated as an outpatient.

• A. This intravenous combination is reserved for moderate to severe CAP requiring hospital admission, not low-severity outpatient disease.
• B. Fluoroquinolones are not first-line for uncomplicated low-severity CAP and should be reserved to limit resistance and adverse effects.
• C. This broad-spectrum intravenous antibiotic is unnecessary and not indicated for low-severity CAP managed as an outpatient.

In a patient with symptoms and radiographic findings suggestive of active pulmonary TB, sputum AFB smear combined with Xpert MTB/RIF (GeneXpert) is the recommended initial diagnostic test per WHO and major guidelines. GeneXpert provides rapid detection of Mycobacterium tuberculosis DNA and rifampicin resistance within about 2 hours, allowing prompt treatment decisions. IGRA and TST detect immune sensitization and cannot distinguish latent from active infection, so they have no role in diagnosing active disease. Culture remains the gold standard for confirmation and drug susceptibility but takes weeks, making it unsuitable as the initial test.

• A. IGRA detects immune sensitization to TB antigens and cannot differentiate latent from active disease.
• B. Culture is the confirmatory gold standard but takes 2-6 weeks, too slow for initial diagnosis.
• D. TST similarly reflects prior exposure or sensitization and is not used to diagnose active pulmonary TB.

The standard first-line regimen for drug-susceptible active TB is a 2-month intensive phase with four drugs: isoniazid, rifampicin, pyrazinamide, and ethambutol (RIPE), followed by a 4-month continuation phase with isoniazid and rifampicin, for a total of 6 months. This combination rapidly reduces bacillary load, prevents emergence of drug resistance, and sterilizes residual organisms. Omitting pyrazinamide or ethambutol during the intensive phase increases the risk of treatment failure and resistance. Ethambutol is included until drug susceptibility results are available, particularly to protect against unrecognized isoniazid resistance.

• A. Omitting isoniazid, a key first-line agent, is not part of the standard initial regimen.
• B. Two-drug therapy alone is inadequate for the intensive phase and risks resistance development.
• C. Omitting pyrazinamide from the intensive phase is substandard and prolongs time to sputum conversion.

Isoniazid causes peripheral neuropathy by increasing renal excretion of pyridoxine and inhibiting its conversion to the active cofactor form, impairing GABA synthesis in peripheral nerves. Prophylactic pyridoxine (vitamin B6), typically 10-25 mg daily, is recommended alongside isoniazid in patients at higher risk, including those with diabetes, alcohol use, malnutrition, HIV infection, or chronic kidney disease, and is often given routinely. Folic acid, vitamin B12, and thiamine deficiencies are not the mechanism underlying isoniazid-induced neuropathy and do not prevent this specific adverse effect.

• B. Folic acid deficiency is not the mechanism of isoniazid neurotoxicity.
• C. Vitamin B12 deficiency causes a different pattern of neuropathy and is unrelated to isoniazid's mechanism.
• D. Thiamine deficiency causes beriberi and Wernicke's encephalopathy, not isoniazid-related neuropathy.

IGRA uses antigens specific to Mycobacterium tuberculosis, such as ESAT-6 and CFP-10, which are absent from the BCG vaccine strain, making it unaffected by prior BCG vaccination. In contrast, the tuberculin skin test uses purified protein derivative, which cross-reacts with BCG and causes false-positive results in vaccinated individuals. In this BCG-vaccinated patient, a large TST with a negative IGRA is consistent with a false-positive TST rather than true latent infection, making IGRA the more specific test in this population. No single test result alone is absolute proof of absence of infection, but IGRA is the preferred test here.

• A. A negative IGRA strongly argues against latent infection but is not an absolute guarantee in every clinical context.
• C. IGRA is more specific, not less, in BCG-vaccinated individuals because it avoids antigens shared with BCG.
• D. TST remains a valid test technically, but its specificity is reduced by BCG cross-reactivity, not invalidated outright.

Oseltamivir is most effective when started within 48 hours of symptom onset, and this patient presents at 30 hours, well within that window. Patients at high risk of influenza complications, including those with diabetes, should receive antiviral treatment regardless of severity to reduce the risk of progression to severe disease, hospitalization, and complications. Waiting for worsening symptoms or hypoxia would delay treatment past the optimal window and increase risk of complications in this high-risk patient. Supportive care alone is insufficient for high-risk individuals even with mild symptoms.

• A. Treatment is still indicated because the patient is within the 48-hour window and has a high-risk comorbidity.
• C. Delaying treatment reduces its efficacy, as benefit is greatest when started early in the illness course.
• D. High-risk patients should be treated regardless of oxygen saturation; waiting for desaturation delays appropriate care.

This clinical picture, with paroxysmal cough, inspiratory whoop, post-tussive vomiting, and a household contact with similar prolonged cough, is classic for pertussis (whooping cough). Macrolides, particularly azithromycin, are first-line treatment for pertussis and are especially important in infants due to high risk of complications such as apnea, pneumonia, and death. Treatment is most effective when started early but is still given during the paroxysmal phase to limit transmission and reduce symptom duration. Amoxicillin-clavulanate, corticosteroids, and bronchodilators are not effective against Bordetella pertussis and have no established role in its management.

• B. Bronchodilators do not address the underlying bacterial infection in pertussis.
• C. Beta-lactams are not effective against Bordetella pertussis.
• D. Corticosteroids have no proven role in treating pertussis.

Most acute infectious diarrhea in immunocompetent adults is self-limited and viral or mild bacterial in origin, resolving within days with oral rehydration and symptomatic care alone. Stool culture is reserved for patients with warning features: high fever, bloody diarrhea, severe or prolonged illness (more than 7 days), immunosuppression, signs of dehydration or sepsis, or suspected outbreak. This patient has mild, non-bloody, afebrile diarrhea with no red flags, so empirical supportive management without investigation is appropriate. Routine antibiotics are not indicated and may prolong carriage or cause resistance.

• A. Empirical antibiotics are not indicated for mild, non-bloody, afebrile diarrhea without red flags.
• B. Stool culture is unnecessary in mild self-limited diarrhea without alarm features.
• C. Colonoscopy is not indicated for acute mild diarrhea without alarm features or chronicity.

This patient shows signs of severe dehydration with hypovolemic shock (hypotension, tachycardia, anuria, lethargy), which requires immediate intravenous isotonic fluid resuscitation such as Ringer's lactate to restore circulating volume before switching to oral rehydration solution for maintenance. Oral rehydration solution contains a specific balance of glucose and electrolytes (sodium, potassium, chloride, citrate) that exploits the glucose-sodium co-transporter to enhance intestinal fluid absorption, but it cannot replace volume fast enough in shock. Antibiotics shorten the duration of illness and carriage but are secondary to volume replacement. Fluid resuscitation is the life-saving priority in severe cholera.

• B. Oral rehydration alone is insufficient in a patient with signs of hypovolemic shock; intravenous fluids are required first.
• C. Antibiotics are adjunctive and must not delay fluid resuscitation in a patient in shock.
• D. Antimotility agents are contraindicated in secretory infectious diarrhea and do not address shock.

Giardiasis should be suspected in a patient with subacute, greasy, malodorous diarrhea and bloating following exposure to untreated freshwater, a classic source of Giardia duodenalis cysts. Stool antigen enzyme immunoassay is sensitive and specific and is the preferred initial test, while microscopic examination of stool for ova and parasites (ideally multiple samples) can also identify cysts or trophozoites. Treatment of confirmed giardiasis is metronidazole, typically 250 mg three times daily for 5-7 days. Serology is not useful for diagnosing active infection, and invasive testing is unnecessary when stool studies are diagnostic.

• B. Antibody testing does not reliably distinguish current from past infection and is not used for diagnosis.
• C. Breath testing evaluates for bacterial overgrowth or lactose intolerance, not parasitic infection.
• D. Colonoscopy is invasive and unnecessary when stool antigen testing is diagnostic.

Recent antibiotic exposure, particularly with clindamycin, fluoroquinolones, or broad-spectrum penicillins/cephalosporins, disrupts normal colonic flora and predisposes to Clostridioides difficile colitis. Current guidelines recommend oral vancomycin or fidaxomicin as first-line therapy for an initial episode, replacing metronidazole, which is now reserved for settings where these agents are unavailable. Oral vancomycin acts locally within the colonic lumen since it is poorly absorbed systemically, achieving high local concentrations against C. difficile. Intravenous vancomycin does not reach the colon in adequate concentrations and is not used for this indication.

• A. Intravenous vancomycin does not achieve adequate luminal colonic concentrations and is ineffective for this indication.
• B. Metronidazole is no longer first-line and is reserved for situations where vancomycin or fidaxomicin are unavailable.
• D. Fluoroquinolones are not effective treatment for C. difficile colitis and are a known risk factor for it.

Hepatitis A virus is transmitted via the fecal-oral route, commonly through close household contact with an infected person, contaminated food, or water. For healthy individuals aged 12 months to 40 years exposed within the past 2 weeks, single-antigen hepatitis A vaccine is the preferred post-exposure prophylaxis because it provides both immediate protection and long-term immunity. Immunoglobulin is reserved for those outside this age range, immunocompromised patients, or those with chronic liver disease, and can be given alongside vaccine in some of these groups. Waiting for serology would delay prophylaxis within the critical window and is not necessary before starting vaccination in a healthy contact.

• A. Immunoglobulin alone is reserved for patients outside the preferred age range or with contraindications to vaccine, not for a healthy young adult contact.
• C. Household contacts of acute hepatitis A require post-exposure prophylaxis regardless of current symptoms, since she may still be in the incubation period.
• D. Delaying prophylaxis to await serology results is unnecessary and risks missing the effective post-exposure window.

The clinical picture of fever, right upper quadrant pain with shoulder radiation, tender hepatomegaly, and a single hypoechoic hepatic lesion with preceding diarrheal illness is classic for amoebic liver abscess caused by Entamoeba histolytica. Serology (serum antibody testing) is highly sensitive and specific in this setting, usually positive within a week of symptom onset, and is the best confirmatory test alongside the characteristic imaging. Aspirate, when obtained, classically shows odorless 'anchovy paste' material with few organisms, but aspiration is not routinely required for diagnosis and is reserved for diagnostic uncertainty or large/threatened rupture. Stool microscopy is often negative in established liver abscess because the organism has already invaded the liver.

• A. Aspiration is not first-line for confirming diagnosis and is reserved for uncertain cases or large abscesses at risk of rupture; Gram stain would not identify a parasite.
• B. Stool microscopy has low sensitivity in established amoebic liver abscess since the organism may no longer be present in the gut lumen.
• D. Blood culture would be relevant for suspected pyogenic liver abscess, not the classic amoebic presentation described.

Isolated positivity for anti-HBs in the absence of anti-HBc (total) indicates immunity acquired through vaccination rather than natural infection, since the vaccine contains only HBsAg and does not generate antibodies against core antigen. In contrast, resolved natural infection produces both anti-HBs and anti-HBc as the immune response targets multiple viral antigens following actual exposure to the whole virus. Acute infection would show HBsAg positivity with IgM anti-HBc, and chronic infection would show persistent HBsAg positivity beyond 6 months with total anti-HBc positive and IgM anti-HBc typically negative. This distinction is clinically important when assessing immunity status before immunosuppression, since only natural infection carries a risk of viral reactivation.

• A. Resolved natural infection requires anti-HBc positivity, which is absent in this vaccinated patient.
• B. Acute infection requires HBsAg and IgM anti-HBc positivity, both of which are negative here.
• C. Chronic infection requires persistent HBsAg positivity, which is negative here.

All patients with a history of injection drug use should be screened for hepatitis C regardless of symptoms, since chronic infection is often asymptomatic until advanced liver disease develops. Once chronic hepatitis C is confirmed by detectable HCV RNA, current guidelines recommend direct-acting antiviral therapy for essentially all patients, as these regimens achieve sustained virologic response (cure) rates exceeding 95% with short treatment courses and minimal side effects. Interferon-based regimens have been replaced by direct-acting antivirals due to their superior efficacy, tolerability, and shorter duration. Simple monitoring without treatment is inappropriate given the availability of highly effective curative therapy, and transplantation is reserved for decompensated cirrhosis, not newly diagnosed uncomplicated chronic infection.

• A. Transplantation evaluation is reserved for decompensated cirrhosis or hepatocellular carcinoma, not newly diagnosed uncomplicated chronic hepatitis C.
• B. Monitoring without treatment is inappropriate given curative direct-acting antiviral therapy is available and recommended for nearly all chronic hepatitis C patients.
• D. Interferon-based regimens are outdated and have been superseded by direct-acting antivirals due to higher cure rates and better tolerability.

After first-aid wound care, the critical next step is prompt reporting to occupational health or the designated infection control officer, who will risk-stratify the exposure, test the source patient's HIV, HBV and HCV status (with consent), and determine the need for post-exposure prophylaxis. Squeezing the wound or using caustic agents is not recommended as it may increase local tissue trauma without reducing transmission risk. Immunoglobulin or antiretroviral prophylaxis should only be started after risk assessment, not empirically before the source's status is known, unless the risk is very high and testing will be delayed.

• A. A tourniquet does not reduce bloodborne pathogen transmission and is not part of needlestick first aid.
• B. Squeezing the wound and using alcohol is not recommended and may increase local trauma.
• D. Hepatitis B immunoglobulin should be guided by the exposed person's vaccination/immunity status and the source's HBsAg status, not given blindly.

The fourth-generation HIV test detects both p24 antigen and HIV antibodies, shortening the window period to approximately 2-4 weeks after exposure compared to 4-12 weeks for antibody-only tests. The p24 antigen appears before antibodies, allowing earlier detection during acute infection when antibody-only assays may still be negative. A negative fourth-generation test at 6 weeks is generally considered sufficiently reassuring per most guidelines, with confirmatory repeat testing at 3 months recommended for complete exclusion in high-risk exposures.

• A. Western blot is a supplemental confirmatory test used after a positive screening result, not a primary screening tool.
• C. CD4 count reflects immune status, not infection detection, and is not used for diagnosis.
• D. Antibody-only tests have a longer window period and may miss early infection at 20 days.

HLA-B*5701 testing is recommended before starting abacavir-containing regimens because individuals who carry this allele are at high risk of a potentially severe hypersensitivity reaction to abacavir. Baseline workup before ART also includes CD4 count, HIV viral load, renal and liver function, hepatitis B and C serology, and resistance testing where available, but HLA-B*5701 is the specific pharmacogenetic test that directly determines whether a particular drug can be safely used. Thyroid function and amylase are not part of standard pre-ART baseline evaluation.

• A. Thyroid function testing is not part of standard pre-ART baseline workup.
• B. Serum amylase is not a routine baseline requirement unless pancreatitis is clinically suspected.
• C. Fasting glucose alone is insufficient and not the specific test guiding antiretroviral drug choice.

Current guidelines recommend ceftriaxone as a single intramuscular dose for gonorrhea, combined with doxycycline for 7 days to cover possible chlamydial co-infection when chlamydia has not been excluded. Azithromycin monotherapy is no longer preferred for gonorrhea due to rising resistance, and doxycycline is now favored over azithromycin for chlamydia except in pregnancy. Ciprofloxacin is not recommended due to widespread gonococcal fluoroquinolone resistance. Benzathine penicillin is used for syphilis, not gonorrhea or chlamydia.

• B. Benzathine penicillin is the treatment for syphilis, not gonorrhea or chlamydia.
• C. Azithromycin monotherapy is no longer recommended for gonorrhea due to increasing resistance and does not adequately cover chlamydia as first-line.
• D. Fluoroquinolone resistance in Neisseria gonorrhoeae is widespread, making ciprofloxacin unreliable.

A positive nontreponemal test (RPR) with a reactive titer confirmed by a positive treponemal-specific assay indicates true syphilis infection, since the treponemal test has high specificity and rules out a biological false positive. Because this patient has no documented history of adequate prior treatment, this represents an untreated infection requiring clinical staging (based on history, examination, and duration) to determine the appropriate benzathine penicillin regimen. Tuberculosis does not cause treponemal test cross-reactivity. The combination of both positive tests in an untreated patient confirms the need for staging and treatment, not observation.

• A. A positive treponemal confirmatory test excludes a biological false positive.
• B. There is no history of prior adequate treatment, so this cannot be assumed to be past treated infection.
• C. Tuberculosis does not cause false-positive treponemal serology, and this explanation is not clinically recognized.

The Jarisch-Herxheimer reaction is a self-limited febrile response that occurs within 24 hours of starting antibiotic treatment for syphilis, caused by the release of lipoproteins and inflammatory cytokines as large numbers of Treponema pallidum organisms are rapidly killed. It is not an allergic reaction and does not indicate treatment failure or require discontinuation of therapy; management is supportive with antipyretics. This reaction is more common in early syphilis stages given the higher spirochete burden and typically resolves within 24-48 hours without specific intervention.

• A. Procaine reactions typically cause immediate anxiety or psychiatric symptoms at the time of injection, not a delayed febrile illness.
• C. Anaphylaxis presents with urticaria, angioedema, or bronchospasm shortly after exposure, not an isolated self-limited fever and myalgia.
• D. A transient febrile reaction does not indicate treatment failure, which is assessed by serologic titers over months.

PCR testing of swab material from a genital lesion is the most sensitive and specific method to confirm herpes simplex virus infection and determine the viral type, and has largely replaced viral culture in clinical practice due to superior sensitivity. Oral valacyclovir started promptly during a first clinical episode shortens the duration of symptoms, lesion healing time, and viral shedding; episodic oral antiviral therapy is standard first-line treatment rather than topical agents or intravenous therapy, which are reserved for severe or disseminated disease. Serology detects past exposure and is not useful for diagnosing an acute lesion.

• A. Viral culture is less sensitive than PCR, and treatment is indicated to reduce symptom duration and shedding in a first episode.
• C. Tzanck smear has poor sensitivity and specificity, and topical acyclovir is not effective first-line therapy for genital herpes.
• D. IgG serology reflects past infection and cannot confirm an acute lesion; intravenous therapy is reserved for severe or disseminated disease.

Bacterial meningitis classically produces a markedly elevated white cell count with neutrophil predominance (>80%), a CSF-to-serum glucose ratio below 0.4 (here 1.6/5.8 = 0.28) due to bacterial consumption of glucose, and elevated protein from blood-brain barrier disruption. This triad reliably distinguishes bacterial from viral causes, where glucose is typically preserved and the cell count is lymphocyte-predominant. Tuberculous meningitis also lowers glucose but evolves over days to weeks with lymphocytic predominance and very high protein. Prompt recognition of the bacterial pattern should trigger immediate empirical antibiotic therapy.

• A. Tuberculous meningitis has a lymphocytic, subacute pattern rather than the acute neutrophilic picture seen here.
• C. Subarachnoid hemorrhage shows xanthochromia and red cells rather than a glucose/protein/cell count abnormality like this.
• D. Viral meningitis typically preserves glucose and shows lymphocytic, not neutrophilic, pleocytosis, which does not match this CSF.

CT head before lumbar puncture is indicated when there are focal neurological deficits, a depressed level of consciousness (such as a reduced Glasgow Coma Scale), papilledema, new-onset seizures, or immunocompromise, because these features raise concern for a mass lesion or raised intracranial pressure that could predispose to herniation after CSF removal. This patient has both an altered level of consciousness and a focal deficit (hemiparesis), meeting criteria for imaging first. Antibiotics should not be delayed for imaging; empirical therapy is given immediately while CT is arranged. MRI is more sensitive for structural detail but is slower and less practical in the acute setting for this specific triage decision.

• A. EEG has no role in deciding the safety of lumbar puncture in suspected meningitis.
• B. Procalcitonin may support a bacterial diagnosis but does not address the risk of herniation from lumbar puncture.
• D. MRI is not the first-line emergency triage tool for this decision; it takes longer and is less readily available acutely.

qSOFA assigns one point each for respiratory rate ≥22/min, systolic blood pressure ≤100 mmHg, and altered mentation (Glasgow Coma Scale <15). This patient scores one point for tachypnea (24/min) and one point for hypotension (98 mmHg), giving a total of 2, which identifies her as at higher risk of poor outcome from sepsis and should prompt further evaluation with full Sepsis-3 criteria and lactate measurement. Heart rate and temperature are not components of qSOFA, though they are part of the broader clinical picture. A normal mental status does not exclude sepsis; qSOFA is a bedside screening tool, not a diagnostic criterion.

• A. Temperature is not a qSOFA component and alone cannot generate any points on this score.
• B. Heart rate is not a qSOFA component; the score is based on respiratory rate, blood pressure and mentation only.
• D. Normal mentation contributes zero qSOFA points but does not rule out sepsis, since the other two criteria are already positive.

This patient meets criteria for septic shock, with hypotension and a lactate above 2 mmol/L despite presumed adequate volume, from a likely pneumonia source. The first-hour bundle for septic shock includes obtaining blood cultures before antibiotics when feasible, administering broad-spectrum empirical antibiotics as soon as possible, and giving an initial 30 mL/kg crystalloid fluid bolus for hypotension or lactate ≥4 mmol/L, alongside remeasuring lactate. Delaying antibiotics for imaging or culture results increases mortality, and vasopressors are added only if hypotension persists after adequate fluid resuscitation, not as an initial substitute for fluids and antibiotics.

• B. Antibiotics must not be delayed for culture or imaging results in septic shock; empirical therapy starts immediately.
• C. Oral antibiotics and delayed reassessment are inadequate for septic shock, which requires immediate intravenous therapy.
• D. Vasopressors are reserved for persistent hypotension after fluid resuscitation, not as first-line therapy before fluids and antibiotics.

The modified Duke criteria define two major criteria: positive blood cultures with a typical endocarditis organism (such as Staphylococcus aureus) from two separate cultures, and echocardiographic evidence of endocardial involvement such as a vegetation, abscess, or new valvular regurgitation. This patient has both, satisfying two major criteria, which alone confirms a definite diagnosis of infective endocarditis. Fever and a predisposing cardiac condition (such as a prosthetic valve) are minor criteria, and vascular phenomena like splinter hemorrhages are also minor criteria, none of which alone are sufficient to establish the diagnosis.

• A. A predisposing cardiac condition is a minor Duke criterion, not a major one.
• B. Fever is classified as a minor Duke criterion, not a major one.
• C. Vascular phenomena are classified as a minor Duke criterion, not a major one.

For uncomplicated cystitis in non-pregnant women, first-line oral agents are nitrofurantoin, trimethoprim-sulfamethoxazole (where local resistance is low), or fosfomycin, based on favorable efficacy, low resistance rates, and minimal collateral damage to normal flora. Nitrofurantoin is typically given for 5 days and is preferred due to its narrow spectrum and low propensity to drive resistance. Fluoroquinolones like ciprofloxacin are reserved for more complicated infections or when first-line agents are unsuitable, due to concerns about resistance and adverse effects. Amoxicillin has high rates of E. coli resistance and is not recommended empirically, and ceftriaxone is a parenteral agent reserved for more severe or complicated infections.

• A. Ceftriaxone is a parenteral antibiotic reserved for complicated or severe infections, not first-line oral therapy for cystitis.
• B. Fluoroquinolones are not first-line due to resistance concerns and should be reserved for complicated or resistant infections.
• D. Amoxicillin has high rates of resistance among common uropathogens and is not recommended for empirical treatment.

Uncomplicated acute pyelonephritis in a hemodynamically stable patient who can tolerate oral intake and medications can be safely managed as an outpatient with an oral fluoroquinolone or other appropriate oral agent guided by local resistance patterns. Indications for hospitalization include inability to tolerate oral intake, hemodynamic instability, pregnancy, uncertain diagnosis, or failure of outpatient therapy. This patient has none of these red flags, so outpatient therapy with close follow-up is appropriate. Imaging is reserved for patients with complicated infection, failure to improve within 48-72 hours, or suspected obstruction.

• A. Observation alone without antibiotics is inappropriate for a confirmed bacterial infection.
• B. Intravenous therapy and admission are unnecessary when the patient is stable and tolerating oral intake.
• C. Imaging is not required upfront in uncomplicated pyelonephritis unless there is no improvement or red flags are present.

Asymptomatic bacteriuria in pregnancy must be treated because it is associated with an increased risk of pyelonephritis, preterm labor, and low birth weight. A single positive culture with a significant colony count is sufficient to warrant treatment in pregnant women, unlike in non-pregnant healthy adults where screening and treatment are generally not indicated. A short course of an appropriate antibiotic such as nitrofurantoin (avoided near term) or amoxicillin based on sensitivity is recommended, followed by a test of cure. Outside pregnancy, asymptomatic bacteriuria is treated only in specific situations such as before urologic procedures.

• A. Fluids and cranberry juice have no proven role in eradicating bacteriuria and are not a substitute for antibiotics.
• B. Treatment should be a defined antibiotic course based on sensitivity, not indefinite prophylaxis without a confirmed treatment course first.
• C. Unlike in non-pregnant adults, asymptomatic bacteriuria in pregnancy requires treatment regardless of symptoms due to maternal and fetal risks.

Catheter-associated bacteriuria is extremely common and represents colonization of the catheter biofilm rather than infection in the absence of systemic or localizing symptoms such as fever, suprapubic tenderness, or altered mental status in a patient without other causes. Treating asymptomatic bacteriuria in catheterized patients does not improve outcomes, promotes antibiotic resistance, and is discouraged by major guidelines. A positive culture alone, regardless of colony count or organism, is not an indication for antibiotics in this setting. Diagnosis of catheter-associated urinary tract infection requires symptoms attributable to the urinary tract plus a significant culture.

• B. Intravenous antibiotics are not indicated for asymptomatic bacteriuria in a catheterized patient.
• C. Renal ultrasound is not indicated in the absence of symptoms suggesting obstruction or upper tract involvement.
• D. Catheter exchange and antibiotics are unnecessary when there are no symptoms of infection; this risks adverse drug effects and resistance.

The clinical picture of fever, cough, conjunctivitis, Koplik spots on the buccal mucosa, and a cephalocaudal spreading maculopapular rash is classic for measles, a highly contagious notifiable disease. Measles is a mandatory notifiable disease in the UAE, and any suspected case must be reported immediately to the relevant health authority (DHA, DOH, or MOHAP) to enable contact tracing and outbreak control. The patient should be isolated, ideally with airborne precautions, since measles spreads via respiratory droplets and aerosols and remains infectious from about 4 days before to 4 days after rash onset. Antibiotics have no role unless a bacterial complication develops, and antivirals such as ribavirin are not standard measles treatment.

• A. Ribavirin is not standard therapy for measles; management is supportive with vitamin A and isolation plus notification.
• C. Measles is a viral infection; antibiotics are not indicated unless a secondary bacterial complication occurs.
• D. Isolation remains necessary during the infectious period, which extends for several days after rash onset.

Varicella (chickenpox) is contagious from about 1-2 days before rash onset until all vesicular lesions have crusted over, which typically takes 5-7 days. Standard public health guidance for school or nursery exclusion is based on this crusting criterion rather than a fixed calendar period or resolution of fever alone, since new lesions can continue to appear for several days while fever may settle earlier. This criterion ensures the child is no longer shedding infectious virus from active vesicles before returning to a group setting. Antiviral therapy, when given, does not shorten the required exclusion period.

• B. Fever can resolve before all lesions have crusted, while the child may still be infectious from active vesicles.
• C. The 21-day period refers to the maximum incubation period before symptom onset, not the exclusion duration after rash appears.
• D. Antiviral therapy does not change the exclusion criterion, which is based on lesion crusting.

Mumps orchitis is the most common complication of mumps in post-pubertal males, typically occurring 4-8 days after the onset of parotitis and presenting with unilateral (occasionally bilateral) testicular pain, swelling, and tenderness. It results from direct viral invasion of the testis and occurs in up to a third of post-pubertal males infected with mumps virus. The temporal association with recent parotid swelling and the absence of urethral discharge point away from a sexually transmitted cause. Mumps orchitis can rarely lead to testicular atrophy and reduced fertility but does not usually cause the sudden, severe pain and abnormal testicular position seen with torsion.

• B. Bacterial orchitis from hematogenous spread is rare and would not typically follow the characteristic timeline after parotitis.
• C. Testicular torsion presents with sudden severe pain and an abnormally positioned, high-riding testis, and is a surgical emergency unrelated to recent parotid swelling.
• D. Chlamydial epididymo-orchitis would typically present with urethral discharge and is not temporally linked to parotitis.

In the UAE national immunization schedule, the first dose of the measles-mumps-rubella (MMR) vaccine is routinely given at 12 months of age, with a second dose given later in the schedule (around 18 months or at school entry depending on the specific emirate protocol). This timing balances the waning of maternal antibodies against measles with the need for early protection, since MMR is a live vaccine typically deferred until after the first birthday. The other listed vaccines are given earlier in infancy as part of the primary vaccination series (birth, 2, 4, and 6 months), not at the 12-month visit.

• B. DTaP is started in early infancy as part of the primary series at 2, 4, and 6 months, not as a first dose at 12 months.
• C. Hepatitis B vaccination begins at birth as part of the birth dose, not at the 12-month visit.
• D. The IPV primary series is completed earlier in infancy (typically by 6 months), with boosters later in childhood, not specifically due at 12 months in this schedule.

Once culture and sensitivity results identify the causative organism and its susceptibility pattern, therapy should be de-escalated to the narrowest-spectrum agent that covers the confirmed pathogen. This reduces selective pressure for resistance, lowers toxicity and cost, and preserves broad-spectrum agents for cases that truly need them. Vancomycin was targeting possible Gram-positive or resistant organisms, which is no longer needed since E. coli is the confirmed cause and is susceptible to a narrower cephalosporin. De-escalation is a core pillar of antimicrobial stewardship programs.

• A. Adding an aminoglycoside broadens coverage further when narrowing is indicated and increases nephrotoxicity risk.
• B. Continuing unnecessarily broad combination therapy increases resistance pressure and adverse effects without added benefit.
• D. Vancomycin targets Gram-positive organisms and is not needed for a sensitive Gram-negative isolate; this fails to de-escalate appropriately.

This patient's history describes an IgE-mediated immediate hypersensitivity reaction (urticaria and angioedema within minutes), indicating a true type I penicillin allergy with risk of cross-reactivity to other beta-lactams. Macrolides such as azithromycin are structurally unrelated to beta-lactams and are a standard alternative for atypical and typical community-acquired pneumonia coverage in penicillin-allergic patients. Cephalosporins and carbapenems share the beta-lactam ring and carry a measurable, though lower, cross-reactivity risk, which is best avoided when the allergy history suggests anaphylaxis. Re-exposure to any penicillin derivative is contraindicated in this context.

• A. Re-administering any penicillin derivative, even combined with clavulanate, risks a repeat severe allergic reaction.
• B. Cephalosporins share the beta-lactam ring and carry cross-reactivity risk, which is unsafe given this history of anaphylaxis-type reaction.
• D. Carbapenems are beta-lactams and, while cross-reactivity is low, they are not first-line when a non-beta-lactam alternative is effective and available.

An elevated vancomycin trough with a rising creatinine indicates vancomycin-induced nephrotoxicity, which results from direct tubular oxidative injury that is more likely at higher trough levels, especially above 15 mcg/mL sustained over time. The appropriate response is to hold the dose, recheck renal function, and adjust subsequent dosing (or interval) based on renal clearance and repeat levels rather than continuing unchanged. Target vancomycin troughs for serious MRSA infections are generally 15-20 mcg/mL, so this level is already supratherapeutic and contributing to toxicity. Switching to another nephrotoxic aminoglycoside without addressing the renal injury would compound the problem.

• A. Increasing the dose further would worsen nephrotoxicity since the level is already supratherapeutic.
• B. Gentamicin is also nephrotoxic and switching without correcting the underlying issue does not address the acute kidney injury.
• C. Continuing an already elevated, nephrotoxic dose risks worsening renal injury.

Aminoglycosides such as gentamicin accumulate in renal proximal tubular cells and the inner ear, causing dose- and duration-dependent nephrotoxicity and irreversible ototoxicity (cochlear and vestibular). Monitoring should include serial serum creatinine to detect acute kidney injury and clinical or audiometric hearing assessment, particularly with prolonged courses, high doses, or concurrent nephrotoxic agents. Peak and trough drug level monitoring is also used to optimize efficacy while minimizing toxicity. Hepatotoxicity, QT prolongation, and bone marrow suppression are not characteristic adverse effects of this drug class.

• B. Aminoglycosides are not typically hepatotoxic; this is not their characteristic toxicity profile.
• C. Bone marrow suppression is not a recognized aminoglycoside toxicity; it is more associated with agents like chloramphenicol or linezolid.
• D. QT prolongation is not a typical aminoglycoside effect; it is more associated with macrolides and fluoroquinolones.

Fluoroquinolones such as ciprofloxacin inhibit collagen synthesis and promote matrix metalloproteinase activity in tendon tissue, increasing the risk of tendinitis and tendon rupture, particularly the Achilles tendon. This risk is markedly increased in patients over 60 years old, those on concurrent corticosteroid therapy, and solid organ transplant recipients, all of which apply to this patient. Regulatory agencies including the FDA and EMA have issued boxed warnings regarding this risk in these populations. Given these combined risk factors, an alternative antibiotic class should be chosen when a suitable option exists.

• B. Trimethoprim-sulfamethoxazole can cause hyperkalemia and nephrotoxicity, and still requires renal function monitoring, especially in transplant patients.
• C. Photosensitivity risk depends on sun exposure and is a recognized but manageable adverse effect, not an absolute contraindication.
• D. Nitrofurantoin requires adequate renal function for efficacy and is not recommended when creatinine clearance is significantly reduced.

Neisseria meningitidis is transmitted via large respiratory droplets generated during coughing, sneezing, or close contact, rather than small airborne particles that remain suspended over distance. Droplet precautions, including a surgical mask for anyone within close proximity and a single room where possible, are indicated and should continue until the patient has completed at least 24 hours of effective antibiotic therapy, after which the organism is no longer considered transmissible. Airborne precautions with N95 respirators are reserved for pathogens like tuberculosis, measles, and varicella that remain suspended in fine aerosols. Contact precautions address pathogens spread by direct or indirect touch and are insufficient alone here.

• A. Contact precautions alone do not address the respiratory droplet transmission risk of meningococcal disease.
• B. Meningococcal meningitis requires droplet precautions beyond standard precautions due to its respiratory transmission route.
• C. Airborne precautions are reserved for pathogens spread by small aerosolized particles such as tuberculosis, measles, and varicella, not meningococcus.

Under UAE public health law, including regulations enforced by the Ministry of Health and Prevention, Dubai Health Authority, and Department of Health Abu Dhabi, hepatitis A is classified as a notifiable communicable disease because of its fecal-oral transmission and outbreak potential, particularly in food handlers. Physicians are legally obligated to report confirmed or suspected cases promptly to the relevant health authority, regardless of disease severity or patient consent, to enable timely public health investigation, contact tracing, and outbreak control measures. Failure to report can result in regulatory penalties. This reporting duty applies especially to occupations with public health implications such as food handling.

• A. Self-limiting course does not exempt a disease from mandatory notification; notifiability is based on public health and outbreak control need.
• C. Mandatory disease notification is a legal public health requirement and does not depend on patient consent.
• D. Reporting obligations apply at the time of diagnosis, not only if complications such as fulminant failure develop.

Following a significant unprotected exposure to smear-positive pulmonary tuberculosis, the appropriate occupational health step is repeat testing with a tuberculin skin test or interferon-gamma release assay at 8-10 weeks post-exposure, since conversion may take this long to become detectable, combined with interim monitoring for symptoms such as cough, fever, or weight loss. If the repeat test converts to positive or she develops symptoms, further evaluation for latent or active tuberculosis and chest radiography would follow. Work restriction is reserved for healthcare workers with confirmed active, infectious tuberculosis, not simply after exposure with a pending test. Starting empirical four-drug therapy is inappropriate without evidence of active disease.

• A. Work restriction is appropriate for confirmed active infectious tuberculosis, not for an asymptomatic exposed worker awaiting test conversion.
• B. A significant high-risk exposure to smear-positive tuberculosis warrants structured follow-up testing, not no action.
• C. Empirical full anti-tuberculous therapy is reserved for confirmed or highly probable active disease, not asymptomatic post-exposure screening.